🔔Stock Alerts via Telegram — Free for All Users

IMAX Stock Risk & Deep Value Analysis

Imax Corp

DVR Score

7.8

out of 10

Solid Pick

What You Need to Know About IMAX Stock

We analyzed Imax Corp using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran IMAX through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Moderate. Here's what we found.

Updated Apr 7, 2026Run Fresh Analysis →

IMAX Risk Analysis & Red Flags

What Could Go Wrong

Prolonged absence or unexpected health complications for CEO Richard Gelfond could disrupt strategic execution, delay critical partnerships, and lead to a loss of investor confidence, potentially causing a significant stock price correction as the company navigates leadership uncertainty during a growth phase.

Risk Matrix

Overall

Moderate

Financial

Low

Market

Medium

Competitive

Medium

Execution

Medium

Regulatory

Low

Red Flags

  • CEO Richard Gelfond's temporary medical leave, creating short-term leadership uncertainty.

  • High trailing P/E (63.76x) suggests a substantial amount of future growth is already priced into the stock.

  • Reliance on a consistent slate of blockbuster films and continued consumer preference for premium cinema experiences, which can be cyclical.

  • Insider selling by CEO (pre-planned option exercise) in March 2026, though under a 10b5-1 plan.

Upcoming Risk Events

  • 📅

    Q1 2026 earnings miss or downward revision of 2026 box office guidance.

  • 📅

    Prolonged or more severe health issues for CEO Richard Gelfond.

  • 📅

    Underperformance of key blockbuster films in the 2026 slate.

  • 📅

    Increased competitive pressure from alternative premium cinema formats or advancements in home entertainment technology.

When to Reconsider

  • 🚪

    Exit if the company misses 2026 full-year global box office guidance of $1.4 billion by more than 10%.

  • 🚪

    Sell if operating (adjusted EBITDA) margins show sustained contraction for two consecutive quarters.

  • 🚪

    Consider exiting if the CEO's medical leave extends significantly or if a permanent leadership transition is announced without a clear succession plan.

Unlock IMAX Risk Analysis & Red Flags

Create a free account to see the full analysis

Investment Thesis

IMAX is a unique play on the premium experiential economy, leveraging its proprietary technology and strong brand to capture significant global box office revenue through an asset-light licensing model. The company's focus on expanding its network, fostering local language content, and deepening studio partnerships for 'Filmed For IMAX' content creates a clear path for robust growth in revenue and free cash flow, offering attractive returns despite the inherent market risks of the cinema industry and recent leadership uncertainty.

Is IMAX Stock Undervalued?

IMAX has demonstrated robust financial performance, with Q4 2025 revenue up 35.1% YoY, global box office up 40% to a record $1.28 billion, and free cash flow soaring 187%. This strong momentum is driven by network expansion, successful local language content, and a promising 2026 film slate, directly addressing previous concerns about the core business's hypergrowth potential. The asset-light licensing model and strong brand provide a durable competitive advantage. While the 63.76x trailing P/E is high, the improving margins and cash flow trajectory support a premium. The temporary medical leave of CEO Richard Gelfond introduces short-term leadership risk, but the underlying business appears resilient and well-positioned for continued strong growth, though achieving a full 10x within 3-5 years from its current scale remains ambitious.

Unlock the full AI analysis for IMAX

Get the complete DVR score, risk analysis, and more

📈

Unlock the full report

Create a free account to see the DVR score, risk flags, and AI analysis.

IMAX Price Targets & Strategy

12-Month Target

$50.00

Bull Case

$60.00

Bear Case

$30.00

Valuation Basis

50x forward P/E on estimated FY26 EPS of $1.00

Entry Strategy

Consider dollar-cost averaging on dips towards the $35-$37 range, which provides a better risk/reward profile than the current price, aligning closer to previous support levels.

Exit Strategy

Take partial profits between $48-$50, and set a stop loss around $35 to protect capital against unforeseen negative developments.

Portfolio Allocation

5% for a moderate risk tolerance

Price Targets & Strategy

Upgrade to Premium for price targets and entry/exit strategies

Is IMAX Financially Healthy?

Valuation

P/E Ratio

44.65

Forward P/E

34.84

PEG Ratio

2.03

Price/Book

4.42

Price/Sales

4.51

Profitability

Net Margin

10.47%

Return on Equity

10.21%

Revenue Growth

16.50%

EPS

$0.71

Balance Sheet

Current Ratio

1.11

Quick Ratio

1.03

Other

Beta (Volatility)

0.61

Does IMAX Have a Competitive Moat?

Sign in to unlock

Moat Rating

🛡️ Narrow

Moat Trend

Expanding

Moat Sources

3 Identified

Brand PowerIntangible Assets/IPEfficient Scale

IMAX's moat is built on its globally recognized premium brand and proprietary technology, creating a unique and desirable cinematic experience that is difficult for competitors to replicate. Its asset-light licensing model and deep studio relationships further entrench its position, enhancing durability through continued content integration.

Moat Erosion Risks

  • Rapid technological advancements in competing cinema formats or high-end home entertainment systems that could diminish IMAX's perceived value.
  • A sustained decline in overall cinema attendance or a major shift in content distribution models by studios.
  • Increased consolidation among commercial exhibitors, potentially giving them greater negotiating power.

IMAX Competitive Moat Analysis

Sign up to see competitive advantages

IMAX Market Intelligence

Sentiment & Insider Activity

Social Sentiment

Neutral-Bullish: Strong Q4 results and positive outlook are generally well-received, but the CEO's recent medical leave introduces a cautious note among investors.

Institutional Sentiment

Positive: Evidenced by 10 buy ratings (0 sell) and recent price target increases from JPMorgan, B. Riley, and Goldman Sachs following strong Q4 earnings.

Insider Activity (Form 4)

CEO Richard L. Gelfond exercised 25,024 stock options and sold all shares for ~$1,004,405 net proceeds in March 2026 (pre-planned 10b5-1 sale). Daniel Manwaring (CEO of IMAX China Holding) exercised vested RSUs and received new grants in March 2026.

Options Flow

Normal options activity; no specific unusual activity was identified in the provided research data.

Earnings Intelligence

Next Earnings

2026-04-22

Surprise Probability

Medium

Historical Earnings Pattern

IMAX tends to react positively to earnings beats, especially when accompanied by strong guidance, as seen with the Q4 2025 results leading to analyst upgrades. However, any negative news or guidance could lead to a pull-back.

Key Metrics to Watch

Q1 2026 Revenue and EPS vs. consensus estimates ($0.18 EPS estimate).Updates to 2026 global box office guidance ($1.4B target).Number of new IMAX system installations and backlog updates.Commentary regarding CEO Richard Gelfond's health and expected return.

Competitive Position

Top Competitor

DOLBY LABS (DLB)

Market Share Trend

Gaining market share within the premium cinema segment, demonstrating strong capture rates (e.g., ≥20% domestic opening box office for several major 2025 releases).

Valuation vs Peers

IMAX trades at a significant premium on trailing P/E compared to traditional cinema exhibitors, justified by its asset-light licensing model, strong brand, and proprietary technology; likely also trades at a premium to tech licensors like Dolby given its direct revenue share model.

Competitive Advantages

  • Proprietary, patented projection and sound technology, offering an unparalleled cinematic experience.
  • Strong global brand recognition and premium association with major blockbuster films and directors.
  • Extensive global network of licensed theaters (1,864 systems across 91 countries), leveraging an asset-light model.
  • Deep relationships with major film studios and directors, leading to exclusive 'Filmed For IMAX' content.

Market Intelligence

Get sentiment, earnings intel, and peer analysis with Premium

What Could Drive IMAX Stock Higher?

Near-Term (0-6 months)

  • Q1 2026 Earnings (4/22/2026), with potential updates on 2026 guidance and CEO's health.
  • Release of major 'Filmed For IMAX' titles in Q2-Q3 2026 (e.g., *The Odyssey*, *Dune: Part Three*, *The Mandalorian and Grogu*).

Medium-Term (6-18 months)

  • Continued global network expansion (434-system backlog represents significant future revenue).
  • Growing contribution from local language film content, which saw 66% growth in 2025.
  • Potential for additional strategic content partnerships leveraging 'Filmed For IMAX' initiative.

Long-Term (18+ months)

  • Expansion into broader experiential entertainment beyond traditional cinema.
  • Further deepening of its content integration and production partnerships, solidifying its premium position.
  • Technological advancements that further differentiate the IMAX experience from in-home entertainment.

Catalysts & Growth Drivers

Upgrade to Premium to see catalysts

What's the Bull Case for IMAX?

  • Consistent YoY revenue growth exceeding 15-20% and continued expansion of adjusted EBITDA margins.

  • Updates indicating a strong return and continued strategic leadership from CEO Richard Gelfond.

  • Acceleration in the number of new IMAX system installations and a healthy backlog conversion rate.

Bull Case Analysis

See what could go right with Premium

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.

How Imax Corp Makes Money

IMAX designs, manufactures, and licenses its proprietary high-resolution cameras, projection systems, and theater sound technologies to commercial cinema operators and institutional venues worldwide. The company generates revenue primarily through its unique joint revenue-sharing model, where it earns a percentage of box office receipts from films shown in IMAX-equipped theaters. Additional revenue streams include direct sales and leases of its projection systems, as well as maintenance services and post-production work to optimize films for the IMAX format. Essentially, IMAX enables a premium, immersive viewing experience that moviegoers are willing to pay more for, and it shares in that success with its partners.

Read Full Business Model Breakdown

FAQ

What is the DVR Score for Imax Corp (IMAX)?

As of April 7, 2026, Imax Corp has a DVR Score of 7.8 out of 10, placing it in the "Solid Pick" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.

What is the market capitalization of Imax Corp?

Imax Corp's market capitalization is approximately $1.7B..

What is the risk level for IMAX stock?

Our analysis rates Imax Corp's overall risk as Moderate. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.

What is the P/E ratio of IMAX?

Imax Corp currently has a price-to-earnings (P/E) ratio of 44.6. This is above the market average, suggesting the stock may be priced for high growth expectations.

Is Imax Corp's revenue growing?

Imax Corp has reported revenue growth of 16.5%. The company is showing strong top-line momentum.

Is IMAX stock profitable?

Imax Corp has a profit margin of 10.5%. The company is profitable but margins are modest.

How often is the IMAX DVR analysis updated?

Our AI-powered analysis of Imax Corp is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on April 7, 2026.

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for IMAX (Imax Corp) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.

Navigated to IMAX Stock Risk & Deep Value Analysis